First Niagara Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$420K Hold
5,690
0.12% 127
2016
Q1
$369K Sell
5,690
-15
-0.3% -$1.02K 0.11% 133
2015
Q4
$439K Buy
5,705
+15
+0.3% +$1.19K 0.12% 128
2015
Q3
$469K Sell
5,690
-279
-5% -$24.8K 0.12% 136
2015
Q2
$526K Buy
5,969
+279
+5% +$25.6K 0.12% 131
2015
Q1
$503K Sell
5,690
-89
-2% -$7.89K 0.11% 139
2014
Q4
$480K Sell
5,779
-110
-2% -$9.12K 0.1% 138
2014
Q3
$496K Buy
5,889
+176
+3% +$14.2K 0.1% 142
2014
Q2
$463K Sell
5,713
-146
-2% -$11.5K 0.1% 151
2014
Q1
$446K Sell
5,859
-112
-2% -$8.16K 0.09% 161
2013
Q4
$431K Hold
5,971
0.08% 166
2013
Q3
$411K Buy
5,971
+845
+16% +$55.9K 0.09% 166
2013
Q2
$325K Buy
+5,126
New +$334K 0.07% 185

Other funds holding NVS

First Niagara Bank's NVS Position: Q2 2016 in Review

First Niagara Bank held its Novartis (NVS) position steady in Q2 2016 at 5,690 shares worth $420K. The position accounts for 0.12% of the portfolio, ranked #127.

First Niagara Bank first reported a position in NVS in Q2 2013 and has held it in 13 quarters since. The position peaked at $526K in Q2 2015. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • First Niagara Bank held 5,690 shares of Novartis worth $420K as of Q2 2016.
  • First Niagara Bank left its Novartis share count unchanged in Q2 2016.
  • Novartis made up 0.12% of First Niagara Bank's portfolio in Q2 2016, its #127 holding.
  • First Niagara Bank first reported a position in Novartis in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Novartis position peaked at $526K in Q2 2015.
  • 879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.